All Categories


Pages

Efficacy of anthelmintic treatment to control parasites

The trials of FECR were conducted on sheep in the Veterinary Institute, Kluang. A total of 60 weaned sheep were selected and divided into six (6) groups. Group A was treated with ivermectin (0.5 ml / 25 kg of body weight), Group B received closantel (1 ml/5 kg of body weight) , Group C was treated with fenbendazole (6 ml/25 kg of body weight), Group D was treated with levamisole (5 ml/10 kg of body weight), Group E was treated with Cydectin (1 ml/5 kg of body weight) and the remaining 10 were untreated controls. Anthelmintic  drugs were  administered orally except for Ivermectin and closantel were administered by subcutaneous injection. Faecal samples were collected from each sheep before treatment and repeated on day 14, 30,45 and 60 post treatment. The worm egg counts were estimated by using McMaster’s method. The results of anthelmintic tests were calculated from the mean number of eggs per gram for each group. The percentage reduction in the faecal egg count was calculated using the change in faecal egg count of the control group as a correction factor. The population of worm was classified as resistant if the adjusted percentage reduction was less than 90%. It is concluded that only levamisole can be used for helminthiasis control. The results showed that worms   was suspected to be resistant to Ivermectin, Closantel , Cydectin and   totally resistance to fenbendazole. The strongyle population is mainly made up of 80% Haemonchus contortus and 20% of species were Oesophagostomum and Bunostomum.    

download


More Info

Upload By : Debbra Marcel

About this Article Paper

Sabariah Basir. Efficacy of anthelmintic treatment to control parasites. 30th Veterinary Association of Malaysia (VAM) Congress. 19th-20th October, 2018. Hilton Hotel, Petaling Jaya, Malaysia.(Abstract of e-Poster Presentation).

 

Sabariah Basir  Department of Veterinary Services  Corresponding author: sabariah.dvs@1govuc.gov.my 


Comments


No comments yet! Be the first:

Your Response



Most Viewed - All Categories